On Health Intelligence this week, Europe gets real about superbugs.
This month in the European Parliament the Public Health Committee is focused on tackling superbugs; in part, MEPs want to curb the use of antibiotics to fight back against the growing risk of antimicrobial resistance.
Rapporteur, French MEP Françoise Grossetête said: “With the World Health Organisation is warning us that the world risks drifting into a post-antibiotic era, in which antibiotic resistance would cause more deaths each year than cancer…”
Speaking at a February Ministerial Conference on Antimicrobial Resistance in Amsterdam, Vytenis Andriukaitis, European Commissioner for Health, said: “…an accumulation of factors, in particular the excessive and inappropriate use of antibiotics, and poor infection control practices, have progressively turned AMR into a massive threat for humankind.”
Europe’s private sector is responding to the risk of a global pandemic with a new generation of innovation.
Sensational new medical research conducted by the University of Ferrara, Italy, proves that Europe can immediately counteract environmental pathogenic multi-resistance; simply by using a special probiotic-based hygiene system, called ‘PCHS’
The Italian research team proved that the Probiotic Cleaning Hygiene System will contribute substantially to healthcare-associated infection risk reduction.
Lead researcher, Professor Sante Mazzacane, said: “The study proves the ability of PCHS to colonise hospital surfaces, replacing pathogenic bacteria with safe bacteria.”
Ferrara-based health service company, Copma, has been a partner in the research.
Copma President, Alberto Rodolfi, remarked that: “Traditional hygiene methods cannot produce these results. What Mazzacane’s research team have produced, is not just good news for Italy, but great news for healthcare practitioners and patients globally.”
Copma CEO, Mario Pinca told health intelligence that: “The clinical implications of this research could result in very significant effects even economically, given the impact that HAIs and their treatment have on healthcare budgets.
